← back to search

Miriam Breunig

University of Regensburg · DE
Area of research
Molecular Biology · Biomaterials
Research interest
Research interests include Chemistry, Nanoparticle, Drug delivery, Nanotechnology, Immunogenicity, and Colloidal gold.
h-index
citations
894
works
41
NIH funding
primary concept
email

Recent publications

Engineering lipid-coated silica nanoparticles as versatile adjuvant delivery platform for the TLR4 agonist MPLA
International Journal of Pharmaceutics 2026cited by 1position: lastdoi
A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles
European Journal of Pharmaceutics and Biopharmaceutics 2026cited by 0position: middledoi
Engineering Liposomes and Polymer Conjugates: A Platform for Mechanistic Complement Activation Studies and Controlled Release Applications
ACS Applied Materials & Interfaces 2026cited by 0position: middledoi
Clickable Turn-On Nanoparticles for Target-Specific Intracellular Activation
ChemRxiv 2026cited by 0position: lastdoi
Development of a Liposome-Based Serological Assay for SARS-CoV-2 Variants with Special Emphasis on Coupling Chemistries Required to Maintain Protein Antigenicity
Analytical Chemistry 2025cited by 4position: middledoi
Development of a Novel Homogeneous Liposome-Based One-Step Assay for SARS-CoV-2 Antibody Detection in Human Serum Based on Fluorescent Liposomes and Complement Activity
Analytical Chemistry 2025cited by 2position: middledoi
Nanoparticles in intraocular drug delivery
Medizinische Genetik 2025cited by 1position: middledoi
Prolonged delivery of HIV-1 vaccine nanoparticles from hydrogels
International Journal of Pharmaceutics 2024cited by 3position: lastdoi
Encapsulation of Pioglitazone into Polymer–Nanoparticles for Potential Treatment of Atherosclerotic Diseases
ACS Applied Bio Materials 2023cited by 12position: lastdoi
Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice
European Journal of Pharmaceutics and Biopharmaceutics 2023cited by 8position: middledoi
Injectable Anhydrous Poly(ethylene glycol) Polymer Liquids Form Protein Depot for Extended Controlled Release Applications Via Rapid In Situ Gelation
Molecular Pharmaceutics 2023cited by 7position: middledoi
A shift of paradigm: From avoiding nanoparticular complement activation in the field of nanomedicines to its exploitation in the context of vaccine development
European Journal of Pharmaceutics and Biopharmaceutics 2023cited by 6position: lastdoi
Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells
European Journal of Pharmaceutics and Biopharmaceutics 2022cited by 9position: middledoi
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy?
Journal of Controlled Release 2021cited by 34position: lastdoi
Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Pharmaceutics 2021cited by 23position: lastdoi
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
Vaccines 2021cited by 13position: middledoi
Angiopoietin-1 Mimetic Nanoparticles for Restoring the Function of Endothelial Cells as Potential Therapeutic for Glaucoma
Pharmaceuticals 2021cited by 0position: lastdoi
Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Pharmaceutics 2020cited by 42position: lastdoi
Considerations for efficient surface functionalization of nanoparticles with a high molecular weight protein as targeting ligand
European Journal of Pharmaceutical Sciences 2020cited by 16position: lastdoi
Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery
European Journal of Pharmaceutics and Biopharmaceutics 2020cited by 12position: lastdoi
Presentation of HIV-1 Envelope Trimers on the Surface of Silica Nanoparticles
Journal of Pharmaceutical Sciences 2019cited by 28position: lastdoi
Causative glaucoma treatment: promising targets and delivery systems
Drug Discovery Today 2019cited by 27position: lastdoi
Critical design criteria for engineering a nanoparticulate HIV-1 vaccine
Journal of Controlled Release 2019cited by 26position: lastdoi
Layer-by-Layer Assembled Nanoparticles for siRNA Delivery
Methods in molecular biology 2019cited by 4position: lastdoi
Distribution of nanoparticles in the anterior chamber of porcine eyes
Acta Ophthalmologica 2019cited by 0position: lastdoi
PLGA microspheres loaded with a ROCK inhibitor as an intravitreally injectable drug delivery system for the management of glaucoma
Acta Ophthalmologica 2019cited by 0position: lastdoi
Intracameral Delivery of Layer‐by‐Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Small 2018cited by 57position: lastdoi
Targeting of CD44 by hyaluronan coated-nanoparticles in outflow tissues – a new therapeutic approach for glaucoma
Investigative Ophthalmology & Visual Science 2018cited by 0position: last
Preventing Obstructions of Nanosized Drug Delivery Systems by the Extracellular Matrix
Advanced Healthcare Materials 2017cited by 54position: lastdoi
Hyaluronan as a promising excipient for ocular drug delivery
European Journal of Pharmaceutics and Biopharmaceutics 2016cited by 73position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Achim Goepferich · University of Regensburg14 papers (2012–2025)Ralf Wagner · University of Regensburg9 papers (2019–2025)David Peterhoff · University of Regensburg7 papers (2019–2024)Raphael Mietzner · University of Regensburg7 papers (2019–2024)Rudolf Fuchshofer · University of Regensburg7 papers (2013–2021)Andreas Ohlmann · University of Regensburg6 papers (2012–2021)Renate Liebl · University of Regensburg6 papers (2012–2026)Stefanie Thalhauser · University of Regensburg6 papers (2019–2022)Franziska Froemel · University of Regensburg5 papers (2018–2021)Jens Konrad · University of Regensburg5 papers (2025–2026)Patrick Neckermann · University of Regensburg4 papers (2021–2025) · 4 papers (2018–2021)Diana Pauly · University of Regensburg4 papers (2020–2026)Robert Hennig · University of Regensburg4 papers (2012–2015)Michaela Guter · University of Regensburg4 papers (2016–2019)Ernst R. Tamm · University of Regensburg4 papers (2012–2021)Clara Barbey · University of Regensburg4 papers (2022–2024)Klaus Pollinger · University of Regensburg4 papers (2012–2015)Luise Tomasetti · University of Regensburg3 papers (2012–2017)Joachim Wegener · Johannes Gutenberg University Mainz3 papers (2019–2026)